Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients
Clinical trial NCT00240994 · COMPLETED
Trial details
- NCT number
- NCT00240994
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2009-11-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.